New England Journal of Medicine · 2014 · 231 citations · 26 references
Pregabalin provided significantly improved treatment outcomes as compared with placebo, and augmentation rates were significantly lower with pregabalin than with 0.5 mg of pramipexole. (Funded by Pfizer; ClinicalTrials.gov number, NCT00806026.).
26
Restless Legs Syndrome Prevalence and Impact
Richard P. Allen, Arthur S. Walters, Jacques Montplaisir et al. · Archives of Internal Medicine · 2005 · 1.2K citations